ACV AUCTIONS INC-A (ACVA)

US00091G1040 - Common Stock

21.02  +0.08 (+0.38%)

After market: 21.02 0 (0%)

Fundamental Rating

3

ACVA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Commercial Services & Supplies industry. While ACVA seems to be doing ok healthwise, there are quite some concerns on its profitability. ACVA is valued quite expensively, but it does show have an excellent growth rating.



2

1. Profitability

1.1 Basic Checks

In the past year ACVA has reported negative net income.
ACVA had a positive operating cash flow in the past year.
ACVA had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ACVA reported negative operating cash flow in multiple years.

1.2 Ratios

ACVA has a Return On Assets of -7.43%. This is in the lower half of the industry: ACVA underperforms 76.83% of its industry peers.
The Return On Equity of ACVA (-16.84%) is worse than 71.95% of its industry peers.
Industry RankSector Rank
ROA -7.43%
ROE -16.84%
ROIC N/A
ROA(3y)-9.09%
ROA(5y)-12.55%
ROE(3y)-17.2%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

ACVA has a Gross Margin of 51.48%. This is amongst the best in the industry. ACVA outperforms 90.24% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ACVA has more shares outstanding
Compared to 1 year ago, ACVA has a worse debt to assets ratio.

2.2 Solvency

ACVA has an Altman-Z score of 3.59. This indicates that ACVA is financially healthy and has little risk of bankruptcy at the moment.
ACVA has a better Altman-Z score (3.59) than 74.39% of its industry peers.
ACVA has a debt to FCF ratio of 13.50. This is a negative value and a sign of low solvency as ACVA would need 13.50 years to pay back of all of its debts.
ACVA has a Debt to FCF ratio (13.50) which is in line with its industry peers.
ACVA has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
ACVA's Debt to Equity ratio of 0.25 is fine compared to the rest of the industry. ACVA outperforms 68.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 13.5
Altman-Z 3.59
ROIC/WACCN/A
WACC8.99%

2.3 Liquidity

ACVA has a Current Ratio of 1.51. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
ACVA has a Current ratio of 1.51. This is comparable to the rest of the industry: ACVA outperforms 47.56% of its industry peers.
ACVA has a Quick Ratio of 1.51. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.51, ACVA is doing good in the industry, outperforming 62.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51

7

3. Growth

3.1 Past

The earnings per share for ACVA have decreased strongly by -17.95% in the last year.
ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.34%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 32.18% on average per year.
EPS 1Y (TTM)-17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)29.34%
Revenue growth 3Y32.18%
Revenue growth 5YN/A
Sales Q2Q%43.96%

3.2 Future

The Earnings Per Share is expected to grow by 46.63% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 25.06% on average over the next years. This is a very strong growth
EPS Next Y-27.62%
EPS Next 2Y26.96%
EPS Next 3Y50.61%
EPS Next 5Y46.63%
Revenue Next Year31.6%
Revenue Next 2Y28.01%
Revenue Next 3Y28.91%
Revenue Next 5Y25.06%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

1

4. Valuation

4.1 Price/Earnings Ratio

ACVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ACVA is valued a bit more expensive than 62.20% of the companies in the same industry.
Industry RankSector Rank
P/FCF 413.64
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as ACVA's earnings are expected to grow with 50.61% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y26.96%
EPS Next 3Y50.61%

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACV AUCTIONS INC-A

NASDAQ:ACVA (1/3/2025, 8:18:23 PM)

After market: 21.02 0 (0%)

21.02

+0.08 (+0.38%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners101.32%
Inst Owner Change1.79%
Ins Owners1.33%
Ins Owner Change-14.63%
Market Cap3.52B
Analysts82
Price Target25.54 (21.5%)
Short Float %5.43%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.39%
Min EPS beat(2)8.37%
Max EPS beat(2)14.41%
EPS beat(4)3
Avg EPS beat(4)-0.14%
Min EPS beat(4)-30.72%
Max EPS beat(4)14.41%
EPS beat(8)7
Avg EPS beat(8)20.08%
EPS beat(12)10
Avg EPS beat(12)15.87%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.75%
Min Revenue beat(2)0.79%
Max Revenue beat(2)4.71%
Revenue beat(4)2
Avg Revenue beat(4)0.71%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)4.71%
Revenue beat(8)4
Avg Revenue beat(8)0.92%
Revenue beat(12)6
Avg Revenue beat(12)1.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.99%
PT rev (3m)9.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.02%
EPS NY rev (1m)1.13%
EPS NY rev (3m)1.97%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.83%
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.91
P/FCF 413.64
P/OCF 83.66
P/B 7.72
P/tB 31.16
EV/EBITDA N/A
EPS(TTM)-0.46
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.05
FCFY0.24%
OCF(TTM)0.25
OCFY1.2%
SpS3.56
BVpS2.72
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.43%
ROE -16.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.48%
FCFM 1.43%
ROA(3y)-9.09%
ROA(5y)-12.55%
ROE(3y)-17.2%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF 13.5
Debt/EBITDA N/A
Cap/Depr 100.83%
Cap/Sales 5.64%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z 3.59
F-Score5
WACC8.99%
ROIC/WACCN/A
Cap/Depr(3y)170.68%
Cap/Depr(5y)198.6%
Cap/Sales(3y)5.11%
Cap/Sales(5y)5.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-17.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y-27.62%
EPS Next 2Y26.96%
EPS Next 3Y50.61%
EPS Next 5Y46.63%
Revenue 1Y (TTM)29.34%
Revenue growth 3Y32.18%
Revenue growth 5YN/A
Sales Q2Q%43.96%
Revenue Next Year31.6%
Revenue Next 2Y28.01%
Revenue Next 3Y28.91%
Revenue Next 5Y25.06%
EBIT growth 1Y11.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.89%
EBIT Next 3Y59.72%
EBIT Next 5Y44.2%
FCF growth 1Y108.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y153.7%
OCF growth 3YN/A
OCF growth 5YN/A